INTRODUCTION
Para-umbilical hernias occur just above or less commonly below the umbilicus. They result from weakness in the linea alba and are more common in women than in men. They rarely occur in children and are most common in adult; it constitutes the 2nd common type of hernias about 22% of all hernias in Egypt. 1 Para-umbilical hernioplasty is mostly safe but there are possible complications like seroma, wound infection, injury to bowel (when hernia contain loops of bowel), wound dehiscence. 2 A seroma is an accumulation of fluid in a tissue that can occur after para-umbilical hernioplasty, the fluid called serum leaks out of nearby damaged blood and lymphatic vessels. Cells are typically present in the fluid, which is normally clear. Seroma formation may be associated with an increased risk of infection and breakdown of the surgical site. Surgical drain tubes with bulb suction devices are used after some surgeries to help reduce the risk of seroma formation. These allow for monitoring the volume of fluid leakage, and once drainage becomes minimal, the drains are removed. Seromas can form shortly after surgery if drains are not used, and they may also occur after removal of a drain.
Small seromas often resolve on their own, although left untreated, they can calcify forming hard knots. Larger seromas often require aspiration (removal of fluid), generally accomplished with a needle. Seromas that become infected may require antibiotic therapy and on rare occasions surgery may be necessary to treat a seroma. 4 Postoperative complications such as wound seroma occur in 5.6% to 42% of cases using the meshes for paraumbilical hernia repair. It can be the reason of postoperative wound infection, suppuration, and hernia recurrence. 5 Tranexamic acid is a synthetic derivative of the amino acid lysine that exerts an anti-fibrinolytic action, used in the prevention and treatment of excessive bleeding both in primary and secondary care, first described in the 1960s; recent years have seen a resurgence of interest in its use in the management of bleeding and particularly in the context of severe trauma. 6 When fibrinolysis exceeds coagulation, unwanted surgical bleeding may occur despite adequate haemostasis. Tranexamic acid is the most commonly used medication to prevent fibrinolysis. It acts by blocking the lysine-binding sites on plasminogen, thereby preventing the activation of plasminogen to plasmin. 1 Tranexamic acid can be administered orally or intravenously, Intravenous administration of tranexamic acid during major surgery has been shown to reduce postoperative bleeding by 34 percent. Intravenous dose of tranexamic acid (10mg /kg body weight) was usually given with induction of anaesthesia in para-umbilical hernioplasty. 6 To the best of our knowledge, no up-to-date studies act on the effect of tranexamic acid on seroma formation and wound infection after paraumbilical hernioplasty.
METHODS
This study included 40 patients divided into two groups with para-umbilical herniaplasty, the study were carried out from January 2018 to January 2019 in Menoufia university hospital (Shebeen Elkom, Egypt) and El zaytoon specialized Hospital (Cairo, Egypt). This is a prospective study, in which the 40 consecutive patients were divided into two groups:  Group A: 20 patients received tranexamic acid intravenous injection by adose of 10 mg/kg IV infusion with induction of anaesthesia and were submitted to para-umbilical herniaplasty.  Group B: 20 patients not received tranexamic acid and were submitted to para-umbilical herniaplasty.
The inclusion criteria were: Uncomplicated paraumbilical hernias and Ages between 21 to 70 years. The exclusion criteria were: Complicated hernias, Hernias associated with medical diseases affecting co-aggulation profile and pregnancy.
In this study we used the same type and size of polyprolene mesh in repair of para-umbilical hernias and the same surgeon did hernioplasty in both hospitals).
Clinical assessment
All patients in both groups were subjected to preoperative assessment both clinically and laboratory, all of them were assessed for vital signs, associated medical diseases (diabetes, hypertension, renal, pulmonary, and heart diseases), any anticoagulation such as (low dose aspirin, anti-platelets, warfarin) or cortico-steroids.
Laboratory assessment
CBC, blood sugar, S. creatinine, liver function tests, and INR were drawn.
Abdominal and pelvic ultra-sonography
It is very useful in determination of the size of the abdominal wall defect, and shows the hernia contents. All patients of both groups were subjected to hernioplasty and on-lay mesh repair through a transverse incision and a suction drain were inserted in all patients. Both groups were compared according: the time for drain removal, the amount of drain outcome on 1 
Statistical analysis
The collected data were organized, tabulated and statistically analyzed using SPSS software (Statistical Package for the Social Sciences, version 21, SPSS Inc. USA). Data were described using mean and standard deviation (SD) and frequencies according to the type of the data (quantitative or categorical respectively). Chisquare and fisher exact test were used for comparison of qualitative variables. We used one way Anova test to compare between means of categorical and numerical data. Significance level (P-value) was adopted, i.e. p< 0.05 for interpretation of results of tests of significance.
RESULTS
As regarding comparison of gender of patients in both groups are found that: In group A 11 males (55% of group) and 9 females(45% of group).while in group B 10 males and 10 females without impact on outcomes of the study with p-value=0.752 (Table 1) .
As regarding comparison of age of patients in both groups are found that: In group A between 23-52 years old while in group B between 21-57 years old without impact on outcomes of the study. P-value=0.860 (Table  1) . About 20% of patients in group A had hypertension. While 25% in group B without statistically significant difference between both groups (P-value=1.00) ( Table 1) . The mean time for drain removal in group A was 6.4±1.2 less than that for group B which was 8±1.6.
 Group A: drains were left for more than 5 days in 5 patients (25% of group). While removed on 5 th day or before in 15 patients (75% of group).  Group B: drains were left for more than 5 days in 14 patients (70% of group).While removed on 5th day or before in 6 patients (30% of group). P-value is 0.001 so tranexamic acid shows positive effect on time of drain stay after operation on this study (Table 2 ).
In comparison between the two groups in the mean amount of fluid coming through drain in ml, we found the mean of volumes as follow:
 Group A: In the 1 st day it was 106.5 ml, in the 3 rd day it was 98 ml and in the 5 th day it was 67.6 ml.  Group B: In the 1 st day it was 157.5 ml, in the 3 rd day it was 104 ml and in the 5 th day it was 93.1 ml.
P-value in 1st day is 0.008, 3 rd day is 0.72 and in 5th day is 0.036 so tranexamic acid shows positive effect on drain amount on 1st and 5 th days and no impact on drain amount on 3rd days on this study (Table 2) . In comparison between the two groups in the occurrence of seroma we found that:
In group A: seroma occurred in 3 patients and in group B seroma occurred in 5 patients. P-value of the study is 0.429 so tranexamic acid shows no impact on seroma on this study (Table 4) .
In comparison between the two groups in the occurence of wound infection we found that:
In group A: wound infection occurred in 3 patients and in group B wound infection occurred in 4 patients. Pvalue=1.00 so tranexamic acid shows no impact on wound infection on this study (Table 4 ).
In comparison between the two groups in treatment of seroma we found that:
 In group a (3 cases with seroma) 2 cases treated by aspiration syringe and 1 case treated by reapplication of drain guided by ultrasound (Table 3) .  In group b (5 cases with seroma) 3 cases treated by aspiration syringe and 2 cases treated by reapplication of drain guided by ultrasound (Table 3) . There are no complications detected from injection of intravenous tranexamic acid in this study. 
DISCUSSION
Abdominal wall hernias are one of the most common surgical problems, and mainly caused by any condition that increases the pressure in the intra-abdominal cavity. 7 All patients of both groups were subjected to hernioplasty and on-lay mesh repair through atransverse incision and a suction drain were inserted in all patients.
In our study, we found that there was no significant relation between age and gender in both groups in occurrence of complications as seroma, wound infection and time of drain removal post-operative and this matches with the study done by Patel et al, in 2014 that showed comparison of intravenous versus topical tranexamic acid in total knee arthroplasty (p-value was 0.342), while Yan-ping et al, that showed risk factors for postoperative seromas in Chinese breast cancer patients, in their study showed significant relation between age and gender in both groups in occurrence of complications as seroma (p-value was 0.004). 8, 9 In this study, we found that there was no significant effect of co-morbidities disease like diabetes mellitus and hypertension on the results of the study (P-value was 0.705, 1.00).
The current study revealed that there was a significant effect of tranexamic acid on drain duration (P-value was 0.001) and this matches with the study done by Suh et al., in 2018 which showed the efficacy of tranexamic acid for hemostasis in patients undergoing high tibial osteotomy (P-value was <0.05).
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The current study revealed that there was a significant effect of tranexamic acid on amount of drain output in 1st and 5 th days post-operative (P-value was 0.008, 0.036 respectively) and non-significant in 3 rd day (P-value was 0.72) may be due to technical human error as patient do this alone in his home and this matches with the study done by Ausen et al, in 2015 which showed that clinical trial of topical tranexamic acid after reduction mammoplasty had a significant effect on amount of drain output (P-value was 0.038).
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The current study revealed that there was no significant effect of tranexamic acid in the development of postoperative seroma (P-value was 0.429) may be due to low dose of tranexamic acid as only single dose as it decrease incidence but not significant and this matche with the study done by Oertli et al, in 1994 which showed that Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer had no significant effect on seroma but decrease it (P-value was 0.2). 12 The current study revealed that there was no significant effect of tranexamic acid in the development of wound infection (P-value was 1.00) and this matches with the study conducted by Ausen et al, in 2015 which showed that clinical trial of topical tranexamic acid after reduction mammoplasty had no significant effect on wound infection (P-value was 0.428).
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CONCLUSION
Our study revealed that tranexamic acid showed significant correlation with decrease duration of drains and less amount of drain volumes in first day postoperative.Our study showed that there is no significant correlation between tranexamic acid and rate of seroma formation. 
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